← Open Payments lookup

SAMUEL POTTER: Open Payments

NPI 1407563109 · MAGNA, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,129 in 82 payments from 26 companies in 2025. Trend: 2023 $304 · 2024 $1,266 · 2025 $2,129

Food & beverage: $2,129
CompanyPaymentsAmount
ABBVIE INC.27$387
Edwards Lifesciences Corporation1$202
AstraZeneca Pharmaceuticals LP5$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$192
Indivior Inc.8$186
Novo Nordisk Inc4$161
GlaxoSmithKline, LLC.3$131
Phathom Pharmaceuticals, Inc.1$125
Corcept Therapeutics3$64
Boston Scientific Corporation2$53

Products named: VRAYLAR, SAPIEN 3 Ultra RESILIA, CAPLYTA, SUBLOCADE, Ozempic, VOQUEZNA, AREXVY, QULIPTA.

Industry payments across UT — which companies pay providers there.